Half-year report · HY

Period2025-12-01 → 2026-05-31
Filed2026-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥4.3bn2025-12-01 → 2026-05-31Cons.Net sales
Revenue¥8.8bn2024-12-01 → 2025-11-30Cons.Net sales (5-year summary)
Revenue¥4.3bn2024-12-01 → 2025-05-31Cons.Net sales
Operating income¥304m2025-12-01 → 2026-05-31Cons.Operating income
Operating income¥199m2024-12-01 → 2025-05-31Cons.Operating income
Ordinary income¥285m2025-12-01 → 2026-05-31Cons.Ordinary income
Ordinary income¥405m2024-12-01 → 2025-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥183m2024-12-01 → 2025-05-31Cons.Ordinary income
Profit before tax¥288m2025-12-01 → 2026-05-31Cons.Income before income taxes
Profit before tax¥183m2024-12-01 → 2025-05-31Cons.Income before income taxes
Net income (owners)¥209m2025-12-01 → 2026-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥298m2024-12-01 → 2025-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥135m2024-12-01 → 2025-05-31Cons.Profit loss attributable to owners of parent
Net income¥209m2025-12-01 → 2026-05-31Cons.Profit loss
Net income¥135m2024-12-01 → 2025-05-31Cons.Profit loss
Total assets¥9.0bnat 2026-05-31Cons.Assets
Total assets¥8.9bnat 2025-11-30Cons.Assets
Total assets¥8.8bnat 2025-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2026-05-31Cons.Liabilities
Total liabilities¥5.7bnat 2025-11-30Cons.Liabilities
Net assets / equity¥3.3bnat 2026-05-31Cons.Net assets
Net assets / equity¥3.1bnat 2025-11-30Cons.Net assets
Net assets / equity¥2.9bnat 2025-05-31Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2026-05-31Cons.Cash and deposits
Cash and deposits¥1.2bnat 2025-11-30Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2026-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.2bnat 2025-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2025-05-31Cons.Cash and cash equivalents
Cash & equivalents¥745mat 2024-11-30vCons.Cash and cash equivalents
Operating cash flow¥1.1bn2025-12-01 → 2026-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥830m2024-12-01 → 2025-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥566m2024-12-01 → 2025-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥138m2025-12-01 → 2026-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥739m2024-12-01 → 2025-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2024-12-01 → 2025-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥228m2025-12-01 → 2026-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥360m2024-12-01 → 2025-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥187m2024-12-01 → 2025-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥171.922025-12-01 → 2026-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥245.112024-12-01 → 2025-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥110.522024-12-01 → 2025-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio36.6%at 2026-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio35.3%at 2025-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.5%at 2025-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentrevenue2025-12-01 → 2026-05-31¥4.3bn
Pharmaceutical Productsreportable segmentrevenue external2025-12-01 → 2026-05-31¥4.3bn
Pharmaceutical Productsreportable segmentsegment profit2025-12-01 → 2026-05-31¥288m
Real Estate Leasingreportable segmentrevenue2025-12-01 → 2026-05-31¥19m
Real Estate Leasingreportable segmentrevenue external2025-12-01 → 2026-05-31¥19m
Real Estate Leasingreportable segmentsegment profit2025-12-01 → 2026-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2025-12-01 → 2026-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-12-01 → 2026-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-12-01 → 2026-05-31¥304m
Pharmaceutical Productsreportable segmentrevenue2024-12-01 → 2025-05-31¥4.3bn
Pharmaceutical Productsreportable segmentrevenue external2024-12-01 → 2025-05-31¥4.3bn
Pharmaceutical Productsreportable segmentsegment profit2024-12-01 → 2025-05-31¥184m
Real Estate Leasingreportable segmentrevenue2024-12-01 → 2025-05-31¥19m
Real Estate Leasingreportable segmentrevenue external2024-12-01 → 2025-05-31¥19m
Real Estate Leasingreportable segmentsegment profit2024-12-01 → 2025-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-12-01 → 2025-05-31¥199m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Increase decrease in net defined benefit liability ope cfPrior1InterimDuration-24384000JPY
Increase decrease in net defined benefit liability ope cfInterimDuration-JPY
Increase decrease in provision for directors bonuses ope cfPrior1InterimDuration-12450000JPY
Increase decrease in provision for directors bonuses ope cfInterimDuration-10848000JPY
Increase decrease in provision for directors retirement benefits ope cfPrior1InterimDuration10953000JPY
Increase decrease in provision for directors retirement benefits ope cfInterimDuration-7731000JPY
Interest and dividends income ope cfPrior1InterimDuration-2957000JPY
Interest and dividends income ope cfInterimDuration-3115000JPY
Foreign exchange losses gains ope cfPrior1InterimDuration558000JPY
Foreign exchange losses gains ope cfInterimDuration6505000JPY
Interest expenses paid on loans and bonds ope cfPrior1InterimDuration17025000JPY
Interest expenses paid on loans and bonds ope cfInterimDuration23538000JPY
Loss on retirement of noncurrent assets ope cfPrior1InterimDuration233000JPY
Loss on retirement of noncurrent assets ope cfInterimDuration15000JPY
Loss gain on sales of investment securities ope cfPrior1InterimDuration-JPY
Loss gain on sales of investment securities ope cfInterimDuration-2691000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration370981000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration1138747000JPY
Decrease increase in inventories ope cfPrior1InterimDuration242818000JPY
Decrease increase in inventories ope cfInterimDuration-484746000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration-263785000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration137603000JPY
Increase decrease in accrued consumption taxes ope cfPrior1InterimDuration24285000JPY
Increase decrease in accrued consumption taxes ope cfInterimDuration-59141000JPY
Other net ope cfPrior1InterimDuration-120469000JPY
Other net ope cfInterimDuration32860000JPY
Subtotal ope cfPrior1InterimDuration623029000JPY
Subtotal ope cfInterimDuration1190760000JPY
Interest and dividends income received ope cf inv cfPrior1InterimDuration2957000JPY
Interest and dividends income received ope cf inv cfInterimDuration2829000JPY
Interest expenses paid ope cf fin cfPrior1InterimDuration-17061000JPY
Interest expenses paid ope cf fin cfInterimDuration-23430000JPY
Income taxes paid ope cfPrior1InterimDuration-42433000JPY
Income taxes paid ope cfInterimDuration-40899000JPY
Net cash provided by used in operating activitiesPrior1InterimDuration566492000JPY
Net cash provided by used in operating activitiesInterimDuration1129260000JPY
Purchase of property plant and equipment inv cfPrior1InterimDuration-215670000JPY
Purchase of property plant and equipment inv cfInterimDuration-139338000JPY
Purchase of intangible assets inv cfPrior1InterimDuration-688000JPY
Purchase of intangible assets inv cfInterimDuration-1956000JPY
Proceeds from sales of investment securities inv cfPrior1InterimDuration-JPY
Proceeds from sales of investment securities inv cfInterimDuration4334000JPY
Other net inv cfPrior1InterimDuration101000JPY
Other net inv cfInterimDuration-1410000JPY
Net cash provided by used in investment activitiesPrior1InterimDuration-216257000JPY
Net cash provided by used in investment activitiesInterimDuration-138371000JPY
Net increase decrease in short term loans payable fin cfPrior1InterimDuration-JPY
Net increase decrease in short term loans payable fin cfInterimDuration-100000000JPY
Proceeds from long term loans payable fin cfPrior1InterimDuration300000000JPY
Proceeds from long term loans payable fin cfInterimDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-11-30pass rounding
balance sheet identityconsolidated 2026-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-11-30pass
statement vs summary · net assetsconsolidated 2026-05-31pass
statement vs summary · net income attributable to parentconsolidated 2024-12-01/2025-05-31pass
statement vs summary · net income attributable to parentconsolidated 2025-12-01/2026-05-31pass
statement vs summary · operating cash flowconsolidated 2024-12-01/2025-05-31pass
statement vs summary · operating cash flowconsolidated 2025-12-01/2026-05-31pass
statement vs summary · revenueconsolidated 2024-12-01/2025-05-31pass
statement vs summary · revenueconsolidated 2025-12-01/2026-05-31pass
statement vs summary · total assetsconsolidated 2025-11-30pass
statement vs summary · total assetsconsolidated 2026-05-31pass